| 标题 |
[求助补充材料]
 Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊：The Lancet 作者：Peter Nash; Bruce Kirkham; Masato Okada; Proton Rahman; Benard Combe; et al 出版日期：2017-05-25 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时，文件已从服务器自动删除，无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)
cdercder
Nole
无极微光
DW
v0id
随风沙ZYX
Dean
aajhajkahna
能不能学术一点
那时花开
秋风
共产主义战士
OK
xing_xing
DOC_XIONG
cocohan
Lbw
呵呵呵
清爽老九
dde
皖公网安备34019202002308
